Normal business management, Hengrui Pharmaceuticals responds to rumors of being involved in the pharmaceutical anti-corruption storm: there are no online rumors, Hengrui Pharmaceuticals | Company | Rumors
Under the anti-corruption storm in the pharmaceutical industry, "Yaomao" Hengrui Pharmaceutical has once again responded to online rumors.
On August 4th, an investor asked Hengrui Pharmaceuticals if the company had any violations or anti-corruption implications for its management, as the decline in the past week was much greater than that of other pharmaceutical stocks. Investors also have questions. It is currently being reported that the Shenzhen Hengrui office has been copied. Is the information true?
Regarding the above question, Hengrui Pharmaceuticals responded on the interactive platform on August 7th, stating that the company, its subsidiaries, and all dispatched agencies have no online rumors, and the short-term stock price fluctuations in the secondary market are affected by multiple factors. The company's daily business management and business conditions are normal.
Recently, anti-corruption measures in the pharmaceutical industry have attracted industry attention, leading to a decline in the stock prices of many pharmaceutical companies. On July 31st, Hengrui Pharmaceutical reported 44.58 yuan per share, closing down 9.11%. As of the close on August 4th, it was priced at 41.07 yuan per share, closing down 2.84%, with a cumulative decline of over 16% in the week.
On August 1st, an investor from Hengrui Pharmaceuticals asked if the company's use of sales expenses was compliant? Hengrui Pharmaceutical responded on August 3rd that please pay attention to the notes to the company's financial statements for sales expense information. The company has always attached great importance to the development of sales compliance, strictly adhering to the bottom line of compliance, continuously strengthening the assessment of the sales team's code of conduct, and continuously improving the compliance awareness of sales personnel.
In fact, the rumor of "Shenzhen office being plagiarized" attracted attention on August 2nd. At that time, Hengrui Pharmaceutical told Pengpai News reporters that after verification, the company and its subsidiaries, as well as all dispatched agencies, currently have no such situation.